471 related articles for article (PubMed ID: 25673440)
1. Efficacy and safety investigation of Kuntai capsule for the add-back therapy of gonadotropin releasing hormone agonist administration to endometriosis patients: a randomized, double-blind, blank- and tibolone-controlled study.
Chen JM; Gao HY; Ding Y; Yuan X; Wang Q; Li Q; Jiang GH
Chin Med J (Engl); 2015 Feb; 128(4):427-32. PubMed ID: 25673440
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of remifemin on peri-menopausal symptoms induced by post-operative GnRH-a therapy for endometriosis: a randomized study versus tibolone.
Chen J; Gao H; Li Q; Cong J; Wu J; Pu D; Jiang G
Med Sci Monit; 2014 Oct; 20():1950-7. PubMed ID: 25321621
[TBL] [Abstract][Full Text] [Related]
3. [Kuntai capsule combined with gonadotropin releasing hormone agonist in treatment of moderate-severe endometriosis: a clinical observation].
Liu CQ; Qin ZX; Jiang FF; Hong T; Wang F
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Nov; 34(11):1288-91. PubMed ID: 25566615
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy and safety of gonadotropin releasing hormone agonist combined with estrogen-dydrogesteronea in treatment of endometriosis].
Long QQ; Zhang SF; Han Y; Chen H; Li XL; Hua KQ; Hu WG
Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):247-51. PubMed ID: 20646533
[TBL] [Abstract][Full Text] [Related]
5. Effects of Kuntai capsule on breast pain and vaginal bleeding in postmenopausal women.
Qi X; Guo Y; Sun L
Pak J Pharm Sci; 2019 Sep; 32(5(Special)):2471-2476. PubMed ID: 31894037
[TBL] [Abstract][Full Text] [Related]
6. Initiation of GnRH agonist treatment on 3-5 days postoperatively in endometriosis patients: a randomized controlled trial.
Gong L; Zhang S; Han Y; Long Q; Zou S; Cao Y
J Clin Pharmacol; 2015 Aug; 55(8):848-53. PubMed ID: 25694383
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of remifemin compared to tibolone for controlling of perimenopausal symptoms].
Bai WP; Wang SY; Liu JL; Geng L; Hu LN; Zhang ZL; Chen SL; Zheng SR
Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):597-600. PubMed ID: 20003788
[TBL] [Abstract][Full Text] [Related]
8. [Effects and safety of gonadotrophin-releasing hormone agonist combined with estradiol patch and oral medroxyprogesterone acetate on endometriosis].
Wang YQ; Zhang SF; Chen X; Zhu J; Hua KQ; Hu WG
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):504-8. PubMed ID: 19957549
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of oral tibolone 1.25 or 2.5 mg/day vs. placebo in postmenopausal women.
Hudita D; Posea C; Ceausu I; Rusu M
Eur Rev Med Pharmacol Sci; 2003; 7(5):117-25. PubMed ID: 15214586
[TBL] [Abstract][Full Text] [Related]
10. GnRH-a-Induced Perimenopausal Rat Modeling and Black Cohosh Preparations' Effect on Rat's Reproductive Endocrine.
Chen J; Wang H; Dong Z; Liu J; Qin Z; Bao M; Yu H; Zhang S; Zhang W; Qi C; Wu J
Front Endocrinol (Lausanne); 2021; 12():683552. PubMed ID: 35002948
[TBL] [Abstract][Full Text] [Related]
11. [Meta-analysis of Kuntai Capsules combined with GnRH-a in treatment of endometriosis].
Liu YN; Zhang S; Xu D; Liu B; Shan JJ; Xu JY; Zhou HF
Zhongguo Zhong Yao Za Zhi; 2020 Apr; 45(8):1933-1941. PubMed ID: 32489080
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of tibolone and menopausal transition: a randomized, double-blind placebo-controlled trial.
Morais-Socorro M; Cavalcanti MA; Martins R; Neto Francisco P; Rezende A; Azevedo G; Almeida M
Gynecol Endocrinol; 2012 Jun; 28(6):483-7. PubMed ID: 22132809
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and tolerability of short-term low-dose estrogen-only add-back therapy during post-operative GnRH agonist treatment for endometriosis.
Kim NY; Ryoo U; Lee DY; Kim MJ; Yoon BK; Choi D
Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):85-9. PubMed ID: 20832162
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelin treatment in patients with endometriosis.
Taskin O; Yalcinoglu AI; Kucuk S; Uryan I; Buhur A; Burak F
Fertil Steril; 1997 Jan; 67(1):40-5. PubMed ID: 8986681
[TBL] [Abstract][Full Text] [Related]
15. A Multi-center, Randomized, Controlled and Open Clinical Trial of Heyan Kuntai Capsule () and Hormone Therapy in Perimenopausal Women.
Sun AJ; Wang YP; Gu B; Zheng TP; Lin SQ; Bai WP; Wei Y; Zhang SF; Zhang Y
Chin J Integr Med; 2018 Jul; 24(7):487-493. PubMed ID: 27650094
[TBL] [Abstract][Full Text] [Related]
16. [Effects of Kuntai Capsule and hormone replacement therapy on cognitive function and mental symptoms of early postmenopausal women: a randomized controlled trial].
Li WJ; Xu LZ; Liu HW; Zhang J; Tang LL; Zhou LL; Zhuang J; Liu Y; Liu XF
Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):321-7. PubMed ID: 20388471
[TBL] [Abstract][Full Text] [Related]
17. [Effects of gonadotropin releasing hormone analogues on chemotherapy-induced ovarian function damage in rats].
Peng P; Yang DZ; Zheng CY; Mo YQ; He YM; Zhang QX
Zhonghua Fu Chan Ke Za Zhi; 2007 Aug; 42(8):546-50. PubMed ID: 17983495
[TBL] [Abstract][Full Text] [Related]
18. The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl).
Lindsay PC; Shaw RW; Bennink HJ; Kicovic P
Fertil Steril; 1996 Feb; 65(2):342-8. PubMed ID: 8566259
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.
Morris EP; Rymer J; Robinson J; Fogelman I
Fertil Steril; 2008 Feb; 89(2):421-8. PubMed ID: 17572410
[TBL] [Abstract][Full Text] [Related]
20. The incidence and characteristics of uterine bleeding during postoperative GnRH agonist treatment combined with tibolone add-back therapy in endometriosis patients of reproductive age.
Shin SY; Min JA; Yoon BK; Bae DS; Choi DS
Eur J Obstet Gynecol Reprod Biol; 2007 Jul; 133(1):90-4. PubMed ID: 16806656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
